|
|
|
|
|
|
Kristin leads the Diagnostics and Life Sciences Practice at Health Advances, a global practice
which combines her consulting and scientific experience to provide results-oriented commercialization
strategies for her clients in the therapeutic, diagnostics, and life sciences sectors, including
focus on launch strategy, pricing, and R&D prioritization for novel products for the research
laboratory, personalized medicine, point-of-care, and mainstream clinical diagnostics. Kristin
is a noted speaker, workshop leader and writer in the diagnostics and life sciences industries,
covering topics such as the future of point-of-care platforms, the commercialization of companion
diagnostics, and innovations in personalized medicine. Most recently, she worked with MassBio to
develop its Personalized Medicine Year, is a judge for the Coulter Translational Research Awards,
and is working with BIO to promote reimbursement reform for personalized medicine products.
Kristin has over 15 years of experience in the diagnostics and drug discovery industries. Prior to
joining Health Advances in 2002, Kristin was a scientist in diagnostics technology development at
Genzyme and genomics research at Genome Therapeutics. She has an undergraduate degree in Biochemistry
from Smith College and a Masters degree in Epidemiology, Health Management, and Maternal and Child
Health from the Harvard School of Public Health.
|
|
 |
|
|
|
|
